Higher CEA concentrations occur in only 5%-40% of CRC patients, while positive findings are frequently reported in cancer-free patients who suffer from benign conditions such as liver injury or inflammatory disorders (53, 62). This evidence concerns the gene CEACAM5 and colorectal carcinoma.